Research On Compensation System For Abnormal Reaction Of Vaccination Postgraduates

The Vaccine Administration Law of the People’s Republic of China(hereinafter referred to as the Vaccine Administration Law),which came into effect on December 1,2019,stipulates that China implements a system for compensating for abnormal reactions to vaccination,and provides monetary compensation to recipients who suffer from abnormal reactions to vaccination.However,there are still many problems in the actual compensation process: "Vaccine Management Law" excludes coupling and psychogenic reactions from abnormal reaction compensation in the scope of abnormal reaction compensation,making the range of abnormal reaction compensation too narrow;prevention The vaccination abnormal reaction identification procedure is complicated and time-consuming,and there is an unfair phenomenon in the identification procedure;the vaccination abnormal reaction compensation varies from province to province,and the difference is large;the compensation amount is too low to make up for the loss of the victim;Commercial insurance is used to compensate the recipients of abnormal vaccination.In fact,the function of commercial insurance in the field of abnormal reaction compensation is insufficient.In view of these problems,this article believes that the scope of compensation for abnormal reactions should be broadened,and coupling and psychogenic reactions should be included in the scope of compensation;simplify the identification of abnormal reactions for vaccination,protect the parties’ right to participate in the procedure,establish an abnormal reaction compensation damage table,and establish High-level expert appraisal team strives for fair and equitable results;reduce the difference in compensation for abnormal reactions of vaccination,increase the degree of humanized compensation for recipients,and moderately reduce the standard of certification;through the introduction of commercial insurance,financial compensation for abnormal reaction compensation.The change of compensation from vaccine enterprises to insurance compensation models encourages recipients and vaccine enterprises to purchase supplementary insurance in addition to basic insurance to increase their security.